You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tisagenlecleucel

Showing 26 - 37 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (CTL019)

Active, not recruiting
Has Results
  • B-cell Acute Lymphoblastic Leukemia
  • CTL019
  • Los Angeles, California
  • +24 more
Jun 23, 2022

Pediatric and Young Adult B-Cell Malignancies After Commercially

Not yet recruiting
  • Lymphoid Leukemia
  • Questionnaire for patients receiving therapy
  • Palo Alto, California
    Stanford University
May 9, 2023

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Leukemia, Lymphoma Trial in Wuhan (ET019003-T Cells)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • ET019003-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Nov 11, 2021

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed

Recruiting
  • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Autologous CAR19 T lymphocytes
  • Prague, Czechia
    Institute of Hematology and Blood Transfusion, Czech Republic
Aug 3, 2022

Hematologic Malignancy Trial in Bologna

Recruiting
  • Hematologic Malignancy
    • Bologna, Italy
      Programma Dipartimentale Terapie Cellulari Avanzate
    Apr 17, 2023

    Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • CD19-targeted chimeric antigen receptor T-cell
    • Kaohsiung, Taiwan
    • +2 more
    Oct 25, 2022

    Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

    Recruiting
    • CAR-T Therapy Complications
      • Bologna, Italy
        IRCC, University Hospital of Bologna
      Mar 18, 2022

      Dose Escalation and Safety Trial in Jerusalem (CART BCMA)

      Recruiting
      • Dose Escalation and Safety
      • CART BCMA
      • Jerusalem, Israel
        Hadassah University Hospital
      Jan 21, 2021

      Cytokine Release Syndrome, COVID19 Trial in Greenville (Therapeutic Plasma Exchange, Ruxolitinib)

      Completed
      Has Results
      • Cytokine Release Syndrome
      • COVID19
      • Greenville, South Carolina
        Prisma Health
      Nov 30, 2021

      Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

      Recruiting
      • DLBCL
      • +8 more
      • Cardiac MRI
      • Bonn, NRW, Germany
        University Hospital Bonn
      Jun 11, 2022

      Non-Hodgkin Lymphoma Trial in Haikou (CD19-TriCAR-T/SILK)

      Unknown status
      • Non-Hodgkin Lymphoma
      • CD19-TriCAR-T/SILK
      • Haikou, Hainan, China
      • +2 more
      Mar 11, 2020